Harrow Health Harrow Health (formerly Imprimis Pharmaceuticals) is a pharmaceutical company dedicated to delivering high quality and innovative medicines to physicians and patients at accessible prices. | |||||
Founding Date | Founding Date 2004 | Founding Date 1901 | Founding Date 2018 | Founding Date 1929 | Founding Date 2012 |
Type | Type Private | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Ramachandrapuram, IN HQ Sangareddy, IN Veliminedu, IN Yavapur, IN | Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more | Locations HK HQ | Locations San Diego, US HQ Cottonwood Heights, US Irvine, US Nashville, US Roxbury Township, US | |
Employees | Employees 1581% increase | Employees 37,0006% increase | Employees 491 | Employees 1,829 | Employees 1331% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 20.8 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.7 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $15.8b (FY, 2023) | Revenue (est.) ¥225.4m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $130.2m (FY, 2023) |
Cost of goods | Cost of goods N/A | Cost of goods $8.2b (FY, 2023) | Cost of goods ¥28.3m (FY, 2023) | Cost of goods N/A | Cost of goods $39.6m (FY, 2023) |
Gross profit | Gross profit N/A | Gross profit $7.6b (FY, 2023) | Gross profit ¥204.2m (FY, 2023) | Gross profit N/A | Gross profit $90.6m (FY, 2023) |
Net income | Net income N/A | Net income ($615m) (FY, 2023) | Net income (¥30.3m) (FY, 2023) | Net income N/A | Net income ($24.4m) (FY, 2023) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 358m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 48.7m |